Can I Realize The Benefits Of Medication Pooling? Common RTSM/IRT Questions Answered

Medication pooling offers sponsors an effective way to minimize drug wastage, reduce shipping costs, and streamline logistics in trials. By leveraging the capabilities of Perceptive eClinical IRT/RTSM systems, sponsors can implement simplified pooling methods that integrate seamlessly into trial setups. A new “entry-level” pooling approach requires only minor adjustments to IRT functionality, enabling drug supply managers to centrally manage and release medication kits across multiple studies. This method eliminates the need for repeated specification updates or cumbersome uploads of packaging lists, reducing risks like duplicate kit releases.

While supply managers have reported significant benefits from medication pooling, success depends on factors like study design and supply chain strategies. Trials sharing the same locations, depots, and participant populations yield the greatest reductions in drug waste. Conversely, disparate depots and non-overlapping protocols can limit pooling efficiency. For sponsors exploring advanced strategies such as just-in-time labeling, early engagement with RTSM consultants is crucial. These experts provide tailored guidance, assess the feasibility of pooling, and support the design of frameworks like “parent studies” to facilitate future scalability.

Whether you’re planning a single trial or an entire program, medication pooling offers a pathway to cost-effective and sustainable clinical trial management. Engaging with RTSM experts early ensures optimal outcomes and alignment with regulatory requirements, paving the way for more efficient drug supply processes.